版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
高質(zhì)量細(xì)胞培養(yǎng)用細(xì)胞因子高純度低內(nèi)毒素高活性完善的質(zhì)量控制體系北京義翹神州科技股份有限公司01高質(zhì)量細(xì)胞培養(yǎng)用細(xì)胞因子細(xì)胞的體外培養(yǎng)需要添加合適的細(xì)胞因子,以維持其正常的生長、增殖或者分化。高質(zhì)量細(xì)胞因子在CAR-T/CAR-NK細(xì)胞治療、類器官培養(yǎng)及干細(xì)胞治療等熱門領(lǐng)域顯得尤為重要,直接關(guān)系到最終應(yīng)用的成敗。義翹神州針對不同細(xì)胞培養(yǎng)的實際需求,精心設(shè)計、研發(fā)和生產(chǎn)了一系列高純度、高活性、高穩(wěn)定性、低內(nèi)毒素的特色細(xì)胞因子產(chǎn)品,特別適用于免疫細(xì)胞、干細(xì)胞、類器官等體外培養(yǎng)應(yīng)用場景。另外,為滿足新藥研發(fā)的不同階段的各個環(huán)節(jié),我們提供GMP級、RUO級細(xì)胞因子,全面加速生物藥的研發(fā)上市進(jìn)程。純度大于95%,經(jīng)SDS
&
SEC-HPLC驗證高活性,經(jīng)ELISA、cell-based
assays驗證
高批間一致性無標(biāo)簽或小標(biāo)簽表達(dá)資質(zhì)證書2024年值得關(guān)注的生長因子供應(yīng)商CNAS證書FDA
DMF備案ISO
9001:2015證書ISO
13485:2016證書GMP證書制劑不含載體蛋白低內(nèi)毒素水平:<5?10
EU/mg經(jīng)過類器官、免疫細(xì)胞、干細(xì)胞等培養(yǎng)驗證
ISO9001/ISO13485/GMP質(zhì)量控制體系產(chǎn)品優(yōu)勢高質(zhì)量細(xì)胞培養(yǎng)用細(xì)胞因子北京義翹神州科技股份有限公司高質(zhì)量細(xì)胞培養(yǎng)用細(xì)胞因子02細(xì)胞因子功能介紹細(xì)胞因子生物學(xué)作用培養(yǎng)類型EGF調(diào)節(jié)和促進(jìn)表皮細(xì)胞的生長與增殖促進(jìn)角膜、皮膚等傷口修復(fù)干細(xì)胞:ESC/iPSC、NSC、MSC類器官:腸道、胃、腦、肝臟、肺、胰腺、前列腺、乳腺、內(nèi)耳、血 管、甲狀腺FGF2誘導(dǎo)內(nèi)皮細(xì)胞生長和增殖促進(jìn)血管新生維持多能干細(xì)胞的自我更新和未分化狀態(tài)干細(xì)胞:ESC/iPSC、NSC、MSC免疫細(xì)胞:T細(xì)胞類器官:腸道、心臟、腦、肝臟、肺、腎臟、胰腺、前列腺、乳腺、內(nèi)耳、血管FGF10促進(jìn)上皮細(xì)胞的增殖和遷移調(diào)節(jié)肺、胃和皮膚等組織的發(fā)育和修復(fù)過程參與細(xì)胞分化、血管生成和神經(jīng)細(xì)胞生長促進(jìn)傷口愈合調(diào)節(jié)肢體和肺等多器官發(fā)育干細(xì)胞:ESC/iPSC、NSC
類器官:胃、心臟、肝臟、肺、胰腺、前列腺、乳腺、甲狀腺VEGF165增強(qiáng)內(nèi)皮細(xì)胞的增殖和存活促進(jìn)血管生成增強(qiáng)血管通透性干細(xì)胞:ESC/iPSC、NSC、HSC免疫細(xì)胞:NK細(xì)胞、樹突細(xì)胞、粒細(xì)胞類器官:血管Activin
A促進(jìn)下丘腦、垂體和性腺激素的合成與分泌調(diào)節(jié)細(xì)胞增殖、分化、傷口修復(fù)以及組織和器官 形成干細(xì)胞:ESC/iPSC類器官:腸道、胃、心臟、肝臟、肺、前列腺GM-CSF促進(jìn)粒細(xì)胞和巨噬細(xì)胞的生長和發(fā)育促進(jìn)骨髓細(xì)胞的產(chǎn)生和分化參與傷口愈合干細(xì)胞:HSC免疫細(xì)胞:單核細(xì)胞/巨噬細(xì)胞、樹突細(xì)胞、粒細(xì)胞FGF4調(diào)節(jié)胚胎發(fā)育、細(xì)胞增殖和細(xì)胞分化促進(jìn)心肌血管生成,脊椎動物肢體發(fā)育促進(jìn)再上皮化和傷口愈合與胃癌發(fā)展相關(guān)干細(xì)胞:ESC/iPSC、NSC、MSC類器官:腸道、胃、心臟、腦、肝臟、腎、甲狀腺IFN-γ調(diào)節(jié)和增強(qiáng)機(jī)體的免疫反應(yīng)抗病毒和抗腫瘤作用調(diào)控細(xì)胞生長和分化促進(jìn)炎癥反應(yīng)干細(xì)胞:HSC免疫細(xì)胞:T細(xì)胞、NK細(xì)胞、單核細(xì)胞/巨噬細(xì)胞、樹突細(xì)胞、
B細(xì)胞說明:
ESC/iPSC:胚胎干細(xì)胞/誘導(dǎo)性多能干細(xì)胞;NSC:神經(jīng)干細(xì)胞;MSC:間充質(zhì)干細(xì)胞;HSC:造血干細(xì)胞。北京義翹神州科技股份有限公司03高質(zhì)量細(xì)胞培養(yǎng)用細(xì)胞因子Human
FGF-10
Protein,
HPLC-verified
(Cat#:
10573-HNAE)經(jīng)肺、腎、胃、肝癌、腎癌、乳腺癌、胃癌等9種類器官培養(yǎng)驗證人小腸類器官 人胃類器官產(chǎn)品驗證數(shù)據(jù)Human
small
intestinal
organoids
werecultured
with
IL22
(Cat#:
13059-HNAE),FGF10
(Cat#:
10573-HNAE),EGF
(Cat#:
50482-MNCH),NOG
(Cat#:
50688-M02H).Data
provided
by
D1
Medical
Technology.Human
stomach
organoids
were
culturedwith
EGF
(Cat#:
50482-MNCH),FGF10
(Cat#:
10573-HNAE),NOG
(Cat#:
50688-M02H),RSPO1
(Cat#:
11083-HNAS).Data
provided
by
D1
Medical
Technology.Human
gastric
cancer
organoids
werecultured
with
EGF
(Cat#:
50482-MNCH),FGF10
(Cat#:
10573-HNAE),NOG
(Cat#:
50688-M02H),RSPO1
(Cat#:
11083-HNAS).Data
provided
by
D1
Medical
Technology.Human
R-Spondin
1/RSPO1
Protein,
HPLC-verified
(Cat#:
11083-HNAS)結(jié)直腸癌類器官LM-P2Day
7 Day
10 Day
14(B)不同形態(tài)的mCRC類器官培養(yǎng)過程;(C)原發(fā)腫瘤和患者衍生類器官的組織病理學(xué)特征。來源:/10.3389/fbioe.2023.1190637Day
1Day
3BFH&ETissue Organoid
OrganoidCRC-
PDO5CRC-
PDO30B
cOM-P6CRC-P10CRC-P14人胃癌類器官Human
FGF-10
Protein,
HPLC-verified
(Cat#:
10573-HNAE)人肺類器官 人肺癌類器官Human
lung
organoids
were
cultured
withFGF2
(Cat#:
10014-HNAE),FGF4(Cat#:
16043-HNAE),FGF7
(Cat#:
10210-H07E),EGF
(Cat#:
50482-MNCH),FGF10
(Cat#:
10573-HNAE),NOG
(Cat#:
50688-M02H),RSPO1
(Cat#:
11083-HNAS).Data
provided
by
D1
Medical
Technology.Human
lung
cancer
organoids
werecultured
with
FGF2
(Cat#:
10014-HNAE),FGF4
(Cat#:
16043-HNAE),FGF7
(Cat#:
10210-H07E),EGF
(Cat#:
50482-MNCH),FGF10
(Cat#:
10573-HNAE),NOG
(Cat#:
50688-M02H),RSPO1
(Cat#:
11083-HNAS).Data
provided
by
D1
Medical
Technology.Human
kidney
organoids
were
culturedwith
FGF7
(Cat#:
10210-H07E),EGF
(Cat#:
50482-MNCH),FGF10
(Cat#:
10573-HNAE),NOG
(Cat#:
50688-M02H),RSPO1
(Cat#:
11083-HNAS),HGF
(Cat#:
10463-HNAS),FGF4
(Cat#:
16043-HNAE).Data
provided
by
D1
Medical
Technology.人腎類器官北京義翹神州科技股份有限公司高質(zhì)量細(xì)胞培養(yǎng)用細(xì)胞因子04產(chǎn)品驗證數(shù)據(jù)Human
EGF
Protein,
HPLC-verified
(Cat#:
10605-HNAE)Three
independent
batches
of
human
EGFprotein
(Cat#:
10605-HNAE)
have
i
dentical
bioactivity.160140120100806040200-20Proliferation,%1E-4
1E-3
0.01
0.1
1
10
100Human
EGF
(ng/mL)高批間一致性Batch
1Batch
2Batch
3iPSC-derived
human
vascular
organoids
werecultured
with
FGF2
(Cat#:
10014-HNAE),
VEGF165(Cat#:
11066-HNAH),
EGF
(Cat#:
10605-HNAE).Red
arrows
represent
vascular
organoids.Human
basic
FGF/FGF2
Protein
(Cat#:
10014-HNAE)人肝癌類器官 人膽管癌類器官Human
liver
cancer
organoids
werecultured
with
FGF2
(Cat#:
10014-HNAE),HGF
(Cat#:
10463-HNAS),FGF7
(Cat#:
10210-H07E),EGF
(Cat#:
50482-MNCH),FGF10
(Cat#:
10573-HNAE),TGFB1
(Cat#:
10804-HNAC),NOG
(Cat#:
50688-M02H),RSPO1
(Cat#:
11083-HNAS).Data
provided
by
D1
Medical
Technology.Human
cholangiocarcinoma
organoidswere
cultured
withFGF2
(Cat#:
10014-HNAE),HGF
(Cat#:
10463-HNAS),FGF7
(Cat#:
10210-H07E),EGF
(Cat#:
50482-MNCH),FGF10
(Cat#:
10573-HNAE),NOG
(Cat#:
50688-M02H),RSPO1
(Cat#:
11083-HNAS).Data
provided
by
D1
Medical
Technology.Human
kidney
cancer
organoids
werecultured
with
FGF2
(Cat#:
10014-HNAE),FGF7
(Cat#:
10210-H07E),EGF
(Cat#:
50482-MNCH),FGF10
(Cat#:
10573-HNAE),NOG
(Cat#:
50688-M02H),RSPO1
(Cat#:
11083-HNAS).Data
provided
by
D1
Medical
Technology.人腎癌類器官高純度HUVEC成管實驗高純度人血管類器官5
10
15
20
25
min≥
95%
as
determined
by
SDS-PAGE.≥
95%
as
determined
by
SEC-HPLC.mAU
400350300250200150100500kDa
M
11666.245.035.025.018.414.4Human/Cynomolgus
VEGF165
Protein
(Cat#:
11066-HNAH)Measured
in
a
cell
proliferation
assayusing
human
umbilical
vein
endothelialcells
(HUVEC).Induction
of
tube
formation
in
human
umbilicalvein
endothelial
cells
(HUVECs)
in
vitro.5
10
15
20 25
min≥
95%
as
determined
by
SDS-PAGE.≥
95%
as
determined
by
SEC-HPLC.mAU05101520kDa
M
11666.245.035.025.018.414.4Proliferation%0.01
0.1110
100VEGF165
Conc.
(ng/mL)活性驗證義翹神州ED50=1.4
(ng/mL)10090
進(jìn)口品牌ED50=4.0
(ng/mL)80706050403020100北京義翹神州科技股份有限公司05高質(zhì)量細(xì)胞培養(yǎng)用細(xì)胞因子Human
IFN
gamma
Protein(Cat#:
11725-HNAE)Activin
A
Protein(Cat#:
10429-HNAH)Human
IL-2
Protein(Cat#:
11848-HNAE2)Human
Flt3
Ligand
Protein(Cat#:
10315-HNAE)Human
IL-21
Protein(Cat#:
10584-HNAE)Human
SCF
Protein(Cat#:
10451-HNAE)產(chǎn)品驗證數(shù)據(jù)≥
95%
as
determined
by
SDS-PAGE.≥
95%
as
determined
by
SEC-HPLC.Measured
in
anti-viral
assays
using
WISHcells
infected
with
vesicular
stomatitisvirus(VSV).Measured
by
its
ability
to
inhibit
proliferationof
MPC-11
cells.5
10
15
20 25
min≥
95%
as
determined
by
SDS-PAGE.≥
95%
as
determined
by
SEC-HPLC.Measured
in
a
cell
proliferation
assay
usingTF-1
human
erythroleukemic
cells.Measured
in
a
cell
proliferation
assay
usingCTLL2.5
10
15
20 25
min≥
95%
as
determined
by
SDS-PAGE.≥
95%
as
determined
by
SEC-HPLC.Measured
in
a
cell
proliferation
assay
usingM-NFS-60
mouse
myelogenous
leukemialymphoblast
cells.5
1015
20 25
minmAU
12010080604020011666.245.035.025.018.414.4kDa
M0.800.750.700.650.600.550.50ED50=8-80
pg/mL0.1
1
10
100Human
IFN
gamma
Conc.
(pg/mL)OD-Blank2040601008001E-41E-3
0.01
0.1
1 10
100
1000Activin
A
Conc.(ng/mL)Inhibition
%50ED
=0.5-5
ng/mLmAU
10080604020011666.245.035.025.018.414.4kDa
MmAU250200150100500kDa
M
11666.245.035.025.018.414.41E-5
1E-4
1E-3
0.01
0.1 1
10
100-500300025002000150010005000Proliferation
%Human
GM-CSF
Conc.
(ng/mL)Human
GM-CSF
Protein(Cat#:
10015-HNAH)3500
ED50=0.06-0.3ng/mL25002000150010005000-5000.1
1
10Human
IL-2
Conc.
(ng/mL)3000
ED50=1-8
ng/mLProliferation,%120010008006004002000-200-4001E-4
1E-3
0.01
0.1
1 10
100Human
IL-21
Conc.
(ng/mL)Measured
by
its
ability
to
induce
Interfer-on-gamma
secretion
by
human
naturalkiller
lymphoma
NK-92
cells.1400
ED
=0.4-2ng/mL50Proliferation,%0.01
0.1
1
10
100Human
Flt3
Ligand
Conc.
(ng/mL)Measured
in
a
cell
proliferation
assay
usingBaF3
mouse
proB
cells
transfected
withmouse
Flt3.5004003002001000Proliferation,%50ED
=1-6
ng/mL5
10
15
20 25
min≥
95%
as
determined
by
SDS-PAGE.≥
95%
as
determined
by
SEC-HPLC.Measured
in
a
cell
proliferation
assay
usingTF-1
human
erythroleukemic
cells.18.4mAU
kDa
M60
11666.250
45.040
35.030
25.020
14.41001E-3
0.01
0.1
1 10
100
1000Human
SCF
Conc.
(ng/mL)50040040030020020010000Proliferation,%ED50=1-8
ng/mL1400120010008006004002000-200Proliferation
%0.01
0.1
1
10 100
1000Human
M-CSF
Conc.
(ng/mL)Human
M-CSF
Protein(Cat#:
11792-HNAH1)1600
ED50=3-15
ng/mL北京義翹神州科技股份有限公司高質(zhì)量細(xì)胞培養(yǎng)用細(xì)胞因子06細(xì)胞因子貨號種屬SEC-HPLC純度內(nèi)毒素宿主Activin
A10429-HNAHHuman,Mouse,
Rat,Cynomolgus,
Rhesus≥
95%<
10
EU/mgHEK293
CellsBMP-210426-HNAE1Human,Mouse,
Rat,Rhesus,
Canine≥
95%
(SDS)<
10
EU/mgE.
coliBMP410609-HNAE2Human≥
95%
(SDS)<
1.0
EU/μgE.coliDKK-110170-H08HHuman≥
95%<
10
EU/mgHEK293
CellsEGF10605-HNAEHuman≥
95%<
5
EU/mgE.
coliFGF210014-HNAEHuman≥
95%
(SDS)<
10
EU/mgE.
coliFGF-416043-HNAEHuman≥
95%<
10
EU/mgE.
coliFGF-910262-HNAEHuman≥
95%<
10
EU/mgE.
coliFGF-1010573-HNAEHuman≥
95%<
5
EU/mgE.
coliFGF-2110911-HNAEHuman≥
95%
(SDS)<
10
EU/mgE.
coliFlt3
Ligand10315-HNAEHuman≥
95%<
10
EU/mgE.
coliG-CSF10007-HNAHHuman≥
95%<
10
EU/mgHEK293
CellsGDNF10561-HNAEHuman≥
95%<
10
EU/mgE.
coliGM-CSF10015-HNAHHuman≥
95%<
10
EU/mgHEK293
CellsHGF10463-HNASHuman≥
95%<
10
EU/mgCHO
Stable
CellsIFN
gamma11725-HNAEHuman≥
95%<
5
EU/mgE.
coli11725-H08HHuman≥
95%<
1.0
EU/μgHEK293
CellsIL-1
beta10139-HNAEHuman≥
95%<
5
EU/mgE.
coliIL-211848-HNAE2Human≥
95%<
5
EU/mgE.
coliIL-311858-HNAEHuman≥
95%<
5
EU/mgE.
coliIL-411846-HNAEHuman≥
95%<
5
EU/mgE.
coliIL-610395-HNAEHuman≥
95%
(SDS)<
10
EU/mgE.
coliIL-711821-HNAEHuman≥
95%<
10
EU/mgE.
coliIL-1010947-HNAEHuman≥
90%<20
EU/mgE.
coliIL-12CT011-H08HHuman≥
95%<
5
EU/mgHEK293
CellsCT050-HNAHHuman≥
95%<
5
EU/mgHEK293
Cells高活性細(xì)胞因子產(chǎn)品列表GMP-grade
availableAnimal-free
available北京義翹神州科技股份有限公司07高質(zhì)量細(xì)胞培養(yǎng)用細(xì)胞因子高活性細(xì)胞因子產(chǎn)品列表細(xì)胞因子貨號種屬SEC-HPLC純度內(nèi)毒素宿主IL-1510360-HNCEHuman≥
95%
(SDS)<20
EU/mgE.
coliIL-1810119-HNCEHuman>
95%<
10
EU/mgE.
coliIL-2110584-HNAEHum
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 二零二五年度智能工廠臨時工就業(yè)合同4篇
- 2025年度廠房折疊門研發(fā)成果轉(zhuǎn)化與技術(shù)合作合同4篇
- 個人培訓(xùn)費用繳納協(xié)議模板版B版
- 2025年度二零二五煤炭產(chǎn)業(yè)技術(shù)創(chuàng)新合同4篇
- 二零二五年智能薦設(shè)備購置與技術(shù)培訓(xùn)合同3篇
- 《“探界者”鐘揚(yáng)》說課稿 2024-2025學(xué)年統(tǒng)編版高中語文必修上冊
- 9《這些是大家的》第一課時說課稿-2024-2025學(xué)年道德與法治二年級上冊統(tǒng)編版
- 二零二四年度快樂教育在線教育平臺建設(shè)合同
- 二零二五版?zhèn)€人住房抵押擔(dān)保合同范本3篇
- 二零二五年度網(wǎng)絡(luò)安全公司股權(quán)轉(zhuǎn)讓簡易合同2篇
- 老年人視覺障礙護(hù)理
- 《腦梗塞的健康教育》課件
- 《請柬及邀請函》課件
- 中小銀行上云趨勢研究分析報告
- 遼寧省普通高中2024-2025學(xué)年高一上學(xué)期12月聯(lián)合考試語文試題(含答案)
- 青海原子城的課程設(shè)計
- 常州大學(xué)《新媒體文案創(chuàng)作與傳播》2023-2024學(xué)年第一學(xué)期期末試卷
- 麻醉蘇醒期躁動患者護(hù)理
- 英語雅思8000詞匯表
- 小學(xué)好詞好句好段摘抄(8篇)
- JT-T-1059.1-2016交通一卡通移動支付技術(shù)規(guī)范第1部分:總則
評論
0/150
提交評論